These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 11385272)
1. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome. Dressler D; Wittstock M; Benecke R Eur Neurol; 2001; 45(4):287-8. PubMed ID: 11385272 [No Abstract] [Full Text] [Related]
2. Botulinum toxin physiology in focal hand and cranial dystonia. Karp BI Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of abductor hallucis focal dystonia with botulinum toxin injection: a case presentation. Rosenberg NS; Odderson IR PM R; 2013 Aug; 5(8):726-8. PubMed ID: 23953019 [No Abstract] [Full Text] [Related]
4. [Treatment of focal dystonia with botulinum toxin A]. Sojer M; Wissel J; Müller J; Poewe W Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045 [TBL] [Abstract][Full Text] [Related]
5. New trends in the science of botulinum toxin-A as applied in dystonia. Pickett A; Rosales RL Int J Neurosci; 2011; 121 Suppl 1():22-34. PubMed ID: 21244295 [TBL] [Abstract][Full Text] [Related]
6. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias. Rosales RL; Ng AR; Santos MM; Fernandez HH Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach. Moscovich M; Chen ZP; Rodriguez R J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097 [TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis. Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200 [TBL] [Abstract][Full Text] [Related]
9. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia. Yoshida K Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609 [TBL] [Abstract][Full Text] [Related]
10. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report. Vazquez-Delgado E; Okeson JP Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318 [TBL] [Abstract][Full Text] [Related]
11. A case of idiopathic lower limb dystonia treated with combined botulinum toxin and phenol nerve block. Bianchini E; Massimiani A; Bemporad J; Giovannelli M Acta Neurol Belg; 2024 Jun; 124(3):1095-1097. PubMed ID: 38133850 [No Abstract] [Full Text] [Related]
12. [Use of botulinum toxin type A in neuro-ORL]. Périé S; Lacau St Guily J Ann Readapt Med Phys; 2003 Jul; 46(6):375-9. PubMed ID: 12928145 [TBL] [Abstract][Full Text] [Related]
13. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition]. Budrewicz S; Koszewicz M; Góral M Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332 [TBL] [Abstract][Full Text] [Related]
14. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. Adler CH; Factor SA; Brin M; Sethi KD Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455 [TBL] [Abstract][Full Text] [Related]
15. Treatment of hyperfunctional lines of the face with botulinum toxin A. Binder WJ; Blitzer A; Brin MF Dermatol Surg; 1998 Nov; 24(11):1198-205. PubMed ID: 9834739 [TBL] [Abstract][Full Text] [Related]
16. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction. Singer C; Papapetropoulos S; Vela L J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568 [No Abstract] [Full Text] [Related]
17. [Botulin A toxin: a highly effective drug in the treatment of focal dystonia]. Timerbaeva SL; Ivanova-Smolenskaia IA; Markova ED; Poleshchuk VV; Karapetian MV; Rebrova OIu Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(5):32-5. PubMed ID: 10849964 [No Abstract] [Full Text] [Related]